• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Israeli-based OurCrowd Launches $50M Medtech Fund

by Jasmine Pennic 03/08/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Israeli-based OurCrowd Launches $50M Medtech Fund

OurCrowd, an Israeli-based global investment platform has announced the launch of the $50 million OurCrowd Medtech Fund. The $50M fund will focus exclusively on investing in disruptive medical technologies and therapeutics with the potential to transform global healthcare delivery and patient outcomes. The announcement marks OurCrowd’s first fund dedicated to the medical technology market.

OurCrowd vets and selects companies invests its own capital and invites its accredited membership of investors and institutional partners to invest alongside in these opportunities. OurCrowd provides support to its portfolio companies, assigns industry experts as mentors, and creates growth opportunities through its network of strategic multinational partnerships.

Medtech Fund Investment Focus

The OurCrowd Medtech Fund will focus on medical devices, therapeutics, medical robotics and new developments in the medical industry. Current notable OurCrowd medtech investments to date include:

– AlphaTau Medical: new radio therapy for solid cancer tumors

– UPnRIDE: an electric wheelchair that enables stable standing and mobility for handicapped individuals

– Insightec: MR-guided focused ultrasound for non-invasive surgery

– MeMed: preventing the misuse of antibiotics

– Zebra Medical Vision: Medical imaging insights platform with algorithm-based assistance for radiologists

– Sight Diagnostics: Point of care blood diagnostics utilizing computer vision

– Memic: Robotic arm that extends & improves upon the surgeon’s natural movements

– Syqe Medical: World’s first selective-dose pharmaceutical grade medicinal plants inhaler

Medtech Fund Managing Partners & Bio

The fund will be led by managing partners Dr. Morris Laster and Dr. Morry Blumenfeld and will be managed by a team of clinical experts with decades of experience in medical technologies and startup growth. Dr. Laster is a healthcare executive and entrepreneur with over 25 years of experience in the biopharmaceutical industry and was responsible for six IPO’s on NASDAQ, AIM, and TASE. He has extensive expertise in the identification, management, and financing of advanced biomedical drugs and technologies. He currently represents OurCrowd as a board member or active chairman for several healthcare portfolio companies.

Dr. Blumenfeld is a prominent authority on the development and commercialization of healthcare technology. Most notably, he was among the managers responsible for the development of GE’s computed tomography (“CT”) and magnetic resonance imaging (“MRI”) product line. He currently serves as a member of various medical technology boards, including Chairman of the Medical Advisory Board at OurCrowd.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Digital Therapeutics, Isreali digital health startups, OurCrowd

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |